Skip to main content
. 2018 Oct 18;4(Suppl 1):e000788. doi: 10.1136/rmdopen-2018-000788

Table 2.

The Relapsing Polychondritis Disease Activity Index (RPDAI), adapted from Arnaud et al 9

Points Points
Constitutional symptoms Cutaneous manifestations
2  Fever (>38°C/100.4°F) 3  Purpura
Rheumatological manifestations Renal manifestations
1  Arthritis 4  Haematuria
Chondritides 6  Proteinuria
3  Manubriosternal chondritis 17  Renal failure
4  Sternoclavicular chondritis Cardiovascular manifestations
4  Costochondritis 9  Pericarditis
9  Auricular chondritis (can be unilateral or bilateral) 16  Large-sized and/or medium-sized vessel involvement
9  Nasal chondritis 17  Myocarditis
Ophthalmological manifestations 18  Acute aortic or mitral insufficiency
5  Episcleritis Neurological manifestations
9  Scleritis 12  Motor or sensorimotor neuropathy
9  Uveitis 22  Encephalitis
11  Corneal ulcer Respiratory manifestations
14  Retinal vasculitis Respiratory chondritis (laryngeal and/or tracheal and/or bronchial chondritis)
Biological data 14  Without acute respiratory failure
3  Raised C reactive protein (>20 mg/L) 24  With acute respiratory failure
ENT manifestations  Other (please explain):
8  Sensorineural deafness
12  Vestibular dysfunction
TOTAL RPDAI SCORE

The scoring should only take into account manifestations attributable to relapsing polychondritis and present during the last 28 days.

ENT, ear, nose and throat.